Co-Diagnostics, Inc. (CODX)
4.61
-0.27
(-5.53%)
USD |
NASDAQ |
Jun 11, 11:01
Co-Diagnostics Profit Margin (Quarterly) : -6.26K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | -6.26K% |
| December 31, 2025 | -43.20K% |
| September 30, 2025 | -4.05K% |
| June 30, 2025 | -4.75K% |
| March 31, 2025 | -14.98K% |
| December 31, 2024 | -7.39K% |
| September 30, 2024 | -4.69K% |
| June 30, 2024 | -4.72K% |
| March 31, 2024 | -3.69K% |
| December 31, 2023 | -412.8% |
| September 30, 2023 | -243.5% |
| June 30, 2023 | -4.51K% |
| March 31, 2023 | -956.0% |
| December 31, 2022 | -1.56K% |
| September 30, 2022 | -26.72% |
| June 30, 2022 | -53.48% |
| March 31, 2022 | 51.61% |
| December 31, 2021 | 36.75% |
| September 30, 2021 | 38.12% |
| June 30, 2021 | 35.77% |
| March 31, 2021 | 39.45% |
| Date | Value |
|---|---|
| December 31, 2020 | 47.18% |
| September 30, 2020 | 72.10% |
| June 30, 2020 | 62.42% |
| March 31, 2020 | -68.79% |
| December 31, 2019 | -1.60K% |
| September 30, 2019 | -4.22K% |
| June 30, 2019 | -2.18K% |
| March 31, 2019 | -40.25K% |
| December 31, 2018 | -18.04K% |
| September 30, 2018 | -16.92K% |
| June 30, 2018 | -14.15K% |
| March 31, 2018 | -13.51K% |
| December 31, 2017 | -57.88K% |
| September 30, 2017 | -149.8K% |
| June 30, 2017 | -34.20K% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | -4.85K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Fractyl Health, Inc. | -- |
| Spectral AI, Inc. | -85.49% |
| Sangamo Therapeutics, Inc. | -2.15K% |
| INmune Bio, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -186.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -146.5% |
| Return on Assets | -124.4% |
| Return on Invested Capital | -139.4% |
| Gross Profit Margin (Quarterly) | -207.7% |
| Operating Margin (Quarterly) | -6.31K% |
| Return on Net Operating Assets | -203.4% |